Audhya Paul K.
SEC insider (Form 3/4/5 filer). CIK 0001860131. CHIEF MEDICAL OFFICER at KalVista Pharmaceuticals, Inc. (KALV). 41 reported Form 4/5 transactions since Sep 2024; latest on Jun 11, 2026. Located in FRAMINGHAM, MA.
Companies Audhya Paul K. has filed insider reports for
- KalVista Pharmaceuticals, Inc. (KALV): Officer, CHIEF MEDICAL OFFICER
Audhya Paul K.
CIK: 0001860131
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
KalVista Pharmaceuticals, Inc.
Discretionary Trading P&L
Holdings
Transaction History (41 total)
- Jun 11, 2026KALV
KalVista Pharmaceuticals, Inc.
DispositionDirect150.3K shares- - May 26, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect2.2K shares at avg. $26.78$60K - May 22, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect5K shares- - May 22, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect2.7K shares at avg. $26.78$72K - May 21, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect6.3K shares- - May 18, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect1K shares at avg. $26.76$28K - May 17, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect2.4K shares- - Apr 17, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect2.7K shares at avg. $20.22$54K - Apr 16, 2026KALV
KalVista Pharmaceuticals, Inc.
ExerciseDirect6.3K shares- - Feb 23, 2026KALV
KalVista Pharmaceuticals, Inc.
SaleDirect5.4K shares at avg. $15.57$83K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 11, 2026 | KALV KalVista Pharmaceuticals, Inc. | Disposition | 150,260 | - | $0 | Direct |
| May 26, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 2,239 | $26.78 | $59,955 | Direct |
| May 22, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 5,000 | - | $0 | Direct |
| May 22, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 2,685 | $26.78 | $71,916 | Direct |
| May 21, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 6,250 | - | $0 | Direct |
| May 18, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 1,032 | $26.76 | $27,616 | Direct |
| May 17, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 2,419 | - | $0 | Direct |
| Apr 17, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 2,686 | $20.22 | $54,301 | Direct |
| Apr 16, 2026 | KALV KalVista Pharmaceuticals, Inc. | Exercise | 6,250 | - | $0 | Direct |
| Feb 23, 2026 | KALV KalVista Pharmaceuticals, Inc. | Sale | 5,354 | $15.57 | $83,345 | Direct |
1-10 of 41 transactions